Compare BBY & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBY | ZBH |
|---|---|---|
| Founded | 1966 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 16.0B |
| IPO Year | 1994 | 2001 |
| Metric | BBY | ZBH |
|---|---|---|
| Price | $78.53 | $88.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 21 |
| Target Price | $76.28 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 4.8M | 1.9M |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 6.54% | 1.20% |
| EPS Growth | ★ 17.76 | N/A |
| EPS | ★ 1.31 | 1.22 |
| Revenue | ★ $41,691,000,000.00 | $8,231,500,000.00 |
| Revenue This Year | $1.15 | $4.96 |
| Revenue Next Year | $1.38 | $3.76 |
| P/E Ratio | ★ $58.92 | $71.53 |
| Revenue Growth | 0.39 | ★ 7.20 |
| 52 Week Low | $55.10 | $79.12 |
| 52 Week High | $84.99 | $108.29 |
| Indicator | BBY | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 73.59 | 57.99 |
| Support Level | $70.38 | $85.38 |
| Resistance Level | $84.33 | $95.31 |
| Average True Range (ATR) | 2.93 | 2.18 |
| MACD | 0.81 | 0.65 |
| Stochastic Oscillator | 98.82 | 76.86 |
Best Buy Co Inc is a pure-play consumer electronics retailer in the USA. It has two reportable segments: Domestic and International. The Domestic and International segments have offerings in six revenue categories. Computing and Mobile Phones, Consumer Electronics, Appliances, Entertainment, Services, and Other. The company has approximately 1,068 stores throughout its Domestic and International segments. It also have vendor store-within-a-store concepts to allow closer vendor partnerships and a higher quality customer experience. The company generates majority of its revenue from the Domestic segment.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.